West Pharmaceutical Services

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WST and other ETFs, options, and stocks.

About WST

West Pharmaceutical Services, Inc. engages in the design, manufacture, and sale of containment and delivery systems for injectable drugs and healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. 

CEO
Eric Mark Green
CEOEric Mark Green
Employees
10,800
Employees10,800
Headquarters
Exton, Pennsylvania
HeadquartersExton, Pennsylvania
Founded
1923
Founded1923
Employees
10,800
Employees10,800

WST Key Statistics

Market cap
23.23B
Market cap23.23B
Price-Earnings ratio
44.16
Price-Earnings ratio44.16
Dividend yield
0.26%
Dividend yield0.26%
Average volume
743.75K
Average volume743.75K
High today
$333.29
High today$333.29
Low today
$327.43
Low today$327.43
Open price
$333.29
Open price$333.29
Volume
453.90K
Volume453.90K
52 Week high
$336.82
52 Week high$336.82
52 Week low
$206.80
52 Week low$206.80

Stock Snapshot

As of today, West Pharmaceutical Services(WST) shares are valued at $328.82. The company's market cap stands at 23.23B, with a P/E ratio of 44.16 and a dividend yield of 26.3%.

On 2026-06-12, West Pharmaceutical Services(WST) stock traded between a low of $327.43 and a high of $333.29. Shares are currently priced at $328.82, which is +0.4% above the low and -1.3% below the high.

West Pharmaceutical Services(WST) shares are trading with a volume of 453.9K, against a daily average of 743.75K.

In the last year, West Pharmaceutical Services(WST) shares hit a 52-week high of $336.82 and a 52-week low of $206.80.

In the last year, West Pharmaceutical Services(WST) shares hit a 52-week high of $336.82 and a 52-week low of $206.80.

WST News

MarketWatch 2d
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch

...

West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
Simply Wall St 3d
Does West Pharmaceutical Services’ New CEO Choice Reframe Its Long‑Term Pharma Services Strategy?

West Pharmaceutical Services has announced that Michel Lagarde will become President and CEO and join the Board on August 31, 2026, succeeding retiring Presiden...

Does West Pharmaceutical Services’ New CEO Choice Reframe Its Long‑Term Pharma Services Strategy?
Seeking Alpha 3d
West Pharma raised to Overweight at Barclays on fundamentals

West Pharmaceutical Services (WST) reached a new 52-week high on Tuesday after Barclays upgraded the syringe maker to Overweight from Equal Weight, citing stron...

West Pharma raised to Overweight at Barclays on fundamentals

Analyst ratings

83%

of 18 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

More WST News

TipRanks 3d
Barclays upgrades West Pharmaceutical on ‘material’ upside to estimates

Barclays analyst Luke Sergott upgraded West Pharmaceutical (WST) to Overweight from Equal Weight with a price target of $400, up from $310. The firm says it ove...

People also own

Based on the portfolios of people who own WST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.